{
    "Trade/Device Name(s)": [
        "Presage\u00ae ST2 Assay",
        "Presage\u00ae ST2 Assay Kit Controls",
        "ST2 Assay"
    ],
    "Submitter Information": "Critical Diagnostics",
    "510(k) Number": "K111452",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093758"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OYG",
        "JJX"
    ],
    "Summary Letter Date": "December 5, 2011",
    "Summary Letter Received Date": "December 6, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1117"
    ],
    "Regulation Name(s)": [
        "B-type Natriuretic Peptide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "ST2"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Microtiter plate"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Critical Diagnostics Presage\u00ae ST2 Assay for quantitative measurement of ST2 in serum or plasma using ELISA to aid prognosis assessment in chronic heart failure patients.",
    "Indications for Use Summary": "Quantitative measurement of ST2 in serum or plasma as an aid in assessing prognosis of patients diagnosed with chronic heart failure, used in conjunction with clinical evaluation.",
    "fda_folder": "Clinical Chemistry"
}